Page last updated: 2024-10-24

carisoprodol and MS (Multiple Sclerosis)

carisoprodol has been researched along with MS (Multiple Sclerosis) in 2 studies

Carisoprodol: A centrally acting skeletal muscle relaxant whose mechanism of action is not completely understood but may be related to its sedative actions. It is used as an adjunct in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1202)
carisoprodol : A carbamate ester that is the mono-N-isopropyl derivative of meprobamate (which is a significant metabolite). Carisoprodol interrupts neuronal communication within the reticular formation and spinal cord, resulting in sedation and alteration in pain perception. It is used as a muscle relaxant in the symptomatic treatment of musculoskeletal conditions associated with painful muscle spasm.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ASHWORTH, B1
Bas, H1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Longitudinal Assessment of Spinal Cord Structural Plasticity Using DTI in SCI Patients[NCT03069222]19 participants (Actual)Observational2016-04-01Completed
Hypertonia in Patients With Cerebral Palsy[NCT00123708]100 participants Observational2005-07-19Completed
ENHANCE: Enhancing Brain Plasticity for Sensorimotor Recovery in Spastic Hemiparesis[NCT02725853]50 participants (Actual)Interventional2016-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for carisoprodol and MS (Multiple Sclerosis)

ArticleYear
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
    The Practitioner, 1964, Volume: 192

    Topics: Biomedical Research; Carisoprodol; Humans; Multiple Sclerosis

1964
[Status of the therapy of multiple sclerosis].
    Therapie der Gegenwart, 1967, Volume: 106, Issue:10

    Topics: Adolescent; Adrenocorticotropic Hormone; Anticonvulsants; Carisoprodol; Czechoslovakia; Humans; Male

1967